| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028482 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of autoimune disease, arthritis, infections, myasthenia gravis, asthma and cancer |
| 03/07/2002 | US20020028473 Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid |
| 03/07/2002 | US20020028469 Generating monoclonal antibodies |
| 03/07/2002 | US20020028464 Diagnosis of diabetes |
| 03/07/2002 | US20020028450 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028214 Hyperconcentration of hepatitis virus C neutralizing antibodies |
| 03/07/2002 | US20020028211 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 03/07/2002 | US20020028204 Inhibits ristocetin-induced platelet aggregation), botrocetin-induced platelet aggregation, and shear stress-induced platelet aggregation of human platelet, and which does not express bleeding action |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | US20020028202 Common gamma chain blocking agents |
| 03/07/2002 | US20020028201 Element A, which is a plastic with a group derived from a carboxy acid (e.g., an acrylate polymer), is hydrogen bonded to an element B (e.g., polyalkylene glycol; coupling physiologically and/or pharmacologically active substances |
| 03/07/2002 | US20020028200 Enhancing the production of antibodies which recognize and bind to FimH of uropathogenic Type-I-fimbriated Escherichia coli, but not to FimH of non-uropathogenic Type I- fimbriated Escherichia coli. |
| 03/07/2002 | US20020028178 Treating CD40+ malignancies comprising administering a therapeutically effective amount of an antibody or antibody fragment which binds to CD40L thereby inhibiting CD40/CD40L interaction or CD40 signaling. |
| 03/07/2002 | DE10041342A1 Preparing vaccine against cancer, useful for treatment or prevention, comprises coupling antibody mimetopes,selected from a phage-display library, to macromolecular carrier |
| 03/07/2002 | DE10039112A1 Preparing antibodies specific for a particular binding site, for use in a sandwich enzyme-linked immunosorbant assay, comprises using an impure antigen solution |
| 03/07/2002 | CA2705366A1 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 03/07/2002 | CA2421503A1 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420944A1 Inhibition of cmv infection and dissemination |
| 03/07/2002 | CA2420877A1 Isomaltulose synthase |
| 03/07/2002 | CA2420876A1 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | CA2420696A1 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420277A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | CA2420276A1 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420062A1 Erbb4 antagonists |
| 03/07/2002 | CA2419661A1 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | CA2419578A1 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/06/2002 | EP1184665A1 Method for measuring protein kinase activity |
| 03/06/2002 | EP1184458A1 Differentially expressed CD46 epitopes, proteinaceous molecules capable of binding thereto, and uses thereof |
| 03/06/2002 | EP1184454A2 Nav2 channel gene-deficient non-human animals |
| 03/06/2002 | EP1184392A1 Stabilized denatured lipoprotein and process for producing the same |
| 03/06/2002 | EP1183390A1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
| 03/06/2002 | EP1183386A1 Tm4sf receptors |
| 03/06/2002 | EP1183374A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof |
| 03/06/2002 | EP1183370A2 Human oxidoreductase proteins |
| 03/06/2002 | EP1183364A1 Groel muteins with improved stability |
| 03/06/2002 | EP1183362A1 Il-1 eta dna and polypeptides |
| 03/06/2002 | EP1183356A2 Gustatory receptors in drosophila |
| 03/06/2002 | EP1183355A1 T-bet compositions and methods of use thereof |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183350A2 Expression products of genes involved in diseases related to cholesterol metabolism |
| 03/06/2002 | EP1183349A1 Tumor-associated antigen (c42) |
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183347A1 Interaction-activated proteins |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 03/06/2002 | EP1183275A2 Combined approach to treatment of cancer with hcg vaccines |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183271A1 Polymer conjugates of hedgehog proteins and uses |
| 03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
| 03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1183036A1 Method for preparing dual virally inactivated immune globulin for intravenous administration |
| 03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
| 03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
| 03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339064A Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 03/06/2002 | CN1338517A Polypeptide-human dihydropteridine reductase 19.47 and polynucleotide for coding it |
| 03/06/2002 | CN1338516A Polypeptide-human prohormone and proteinogen convertase hPC135.97 and polynucleotide for coding it |
| 03/06/2002 | CN1338472A Polypeptide-human zinc finger protein 75.68 and polynucleotide for coding it |
| 03/06/2002 | CN1338471A Polypeptide-human rhamnose bound lectin 38.06 and polynucleotide for coding it |
| 03/06/2002 | CN1338470A Polypeptide-human myofibre protein 9.35 and polynucleotide for coding it |
| 03/06/2002 | CN1338469A Polypeptide-human l1 factor ORF2 associated protein 10.45 and polynucleotide for coding it |
| 03/06/2002 | CN1338468A Polypeptide-human arylhydrocarbon receptor protein 15.75 and polynucleotide for coding it |
| 03/06/2002 | CN1338467A Polypeptide-human gas vacuole protein GVPc 10.23 and polynucleotide for coding it |
| 03/06/2002 | CN1338465A Polypeptide-alpha-catenin 10.34 and polynucleotide for coding it |
| 03/06/2002 | CN1338464A Polypeptide-MEN2 associated FBRNP protein 9.79 and polynucleotide for coding it |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/05/2002 | US6353153 Enhanced transport with a plastid membrane transport protein |
| 03/05/2002 | US6353150 Chimeric mammals with human hematopoietic cells |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352846 A polypeptide; for transgenic plants with increased crop yields |
| 03/05/2002 | US6352836 Dirofilaria and brugia thioredoxin peroxidase type-2 proteins and uses thereof |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | US6352831 Glycolipid complexes and their uses |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | CA1341345C Expression of foreign genes in drosophila cells |
| 02/28/2002 | WO2002016939A2 Methods of diagnosis of cancer and screening for cancer modulators |
| 02/28/2002 | WO2002016657A1 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |